HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanjoo Suh Selected Research

Breast Neoplasms (Breast Cancer)

1/2023Inhibitors of Keap1-Nrf2 protein-protein interaction reduce estrogen responsive gene expression and oxidative stress in estrogen receptor-positive breast cancer.
3/2021Understanding the Mechanistic Link between Bisphenol A and Cancer Stem Cells: A Cancer Prevention Perspective.
1/2020Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds.
1/2018Tocopherols inhibit estrogen-induced cancer stemness and OCT4 signaling in breast cancer.
12/2017Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis.
10/2017Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.
10/2017Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.
3/2017Inhibitory Effects of γ- and δ-Tocopherols on Estrogen-Stimulated Breast Cancer In Vitro and In Vivo.
10/2016Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.
3/2016Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nanjoo Suh Research Topics

Disease

56Neoplasms (Cancer)
11/2023 - 01/2002
35Breast Neoplasms (Breast Cancer)
01/2023 - 10/2002
28Carcinogenesis
11/2022 - 07/2006
9Colonic Neoplasms (Colon Cancer)
01/2017 - 01/2007
7Neoplasm Metastasis (Metastasis)
01/2021 - 03/2011
5Inflammation (Inflammations)
11/2023 - 10/2002
5Prostatic Neoplasms (Prostate Cancer)
03/2013 - 10/2006
4Noninfiltrating Intraductal Carcinoma (DCIS)
01/2020 - 06/2014
4Adenocarcinoma
01/2017 - 10/2006
4Aberrant Crypt Foci
01/2013 - 01/2007
3Hyperplasia
09/2015 - 11/2011
3Body Weight (Weight, Body)
03/2011 - 01/2007
3Leukemia
06/2006 - 05/2002
2Triple Negative Breast Neoplasms
10/2017 - 01/2014
2Prostatic Intraepithelial Neoplasia
02/2016 - 10/2006
2Lung Neoplasms (Lung Cancer)
01/2013 - 01/2002
2Insulin Resistance
07/2009 - 10/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2007 - 01/2002
2Myeloid Leukemia (Leukemia, Myelocytic)
06/2006 - 01/2002
1Edema (Dropsy)
11/2023
1Skin Neoplasms (Skin Cancer)
11/2022
1Obesity
06/2022
1Non-alcoholic Fatty Liver Disease
10/2021
1Breast Ductal Carcinoma
01/2020
1Colitis
01/2017

Drug/Important Bio-Agent (IBA)

19Tocopherols (Tocopherol)IBA
01/2020 - 01/2007
13Vitamin DFDA LinkGeneric
01/2020 - 07/2006
12TriterpenesIBA
11/2022 - 01/2002
10Estrogens (Estrogen)FDA Link
01/2023 - 06/2009
10bardoxoloneIBA
11/2022 - 01/2002
101,25- dihydroxy- 21- (3- hydroxy- 3- methyl- 4,4,4- tributyl)- 23- yne- 26,27- hexafluorocholecalciferolIBA
01/2020 - 07/2010
9Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2002
9Vitamin EFDA LinkGeneric
01/2020 - 06/2009
8AntioxidantsIBA
01/2023 - 04/2009
7Estrogen ReceptorsIBA
01/2023 - 05/2004
6Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2017 - 01/2007
61- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA
01/2014 - 07/2003
5CarcinogensIBA
01/2017 - 10/2002
5StilbenesIBA
09/2010 - 01/2007
5AcidsIBA
11/2007 - 05/2002
4AzoxymethaneIBA
01/2013 - 01/2007
4Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
11/2012 - 10/2002
4pterostilbeneIBA
07/2010 - 01/2007
3hydroxide ionIBA
01/2020 - 04/2015
3Biomarkers (Surrogate Marker)IBA
10/2017 - 04/2009
3CytokinesIBA
03/2016 - 07/2009
3LigandsIBA
05/2013 - 06/2002
3Cholecalciferol (Vitamin D3)FDA Link
01/2013 - 07/2006
3Caspase 3 (Caspase-3)IBA
11/2012 - 05/2002
3Cyclin D1IBA
01/2012 - 07/2010
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2011 - 07/2007
3ResveratrolIBA
09/2010 - 10/2008
3alpha-TocopherolFDA Link
04/2010 - 04/2009
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2009 - 05/2002
3EnzymesIBA
04/2009 - 02/2004
3LG 100268IBA
10/2006 - 10/2002
3Selective Estrogen Receptor Modulators (SERM)IBA
10/2006 - 10/2002
3LY 353381 (LY353381)IBA
10/2006 - 10/2002
2TocotrienolsIBA
01/2020 - 04/2010
2RNA (Ribonucleic Acid)IBA
01/2020 - 12/2017
2benzocycloheptapyridineIBA
01/2017 - 02/2016
22- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2017 - 02/2016
2ErbB Receptors (EGF Receptor)IBA
10/2015 - 09/2013
2PhytochemicalsIBA
03/2013 - 10/2008
2NF-kappa B (NF-kB)IBA
07/2010 - 05/2002
2gamma-TocopherolIBA
04/2010 - 04/2009
2CholesterolIBA
07/2009 - 10/2008
2PPAR gammaIBA
06/2009 - 06/2002
2Transforming Growth Factor beta (TGF-beta)IBA
12/2007 - 05/2004
2Caspase 8 (Caspase-8)IBA
06/2005 - 05/2002
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2003 - 10/2002
2bardoxolone methylIBA
01/2002 - 01/2002
1isothiocyanic acidIBA
11/2023
1Therapeutic UsesIBA
11/2023
1lipoarabinomannan (LAM)IBA
11/2023
1Environmental CarcinogensIBA
11/2022
1tanshinoneIBA
06/2022
1Histones (Histone)IBA
10/2021
1Endocrine DisruptorsIBA
03/2021
1bisphenol AIBA
03/2021
1ElementsIBA
01/2021
1Keratin-5 (Keratin 5)IBA
10/2017
13-nitrotyrosineIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2017
1Dextrans (Dextran)FDA Link
01/2017
1anthraceneIBA
10/2016
1Phenobarbital (Luminal)FDA Link
10/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2016
1Free RadicalsIBA
10/2016
1Interleukin-6 (Interleukin 6)IBA
03/2016
1Lapatinib (GW572016)FDA Link
10/2015
1Trastuzumab (Herceptin)FDA Link
10/2015
1Epithelial Cell Adhesion MoleculeIBA
04/2015
1Calcitriol Receptors (Calcitriol Receptor)IBA
06/2014

Therapy/Procedure

10Therapeutics
01/2021 - 06/2002
4Chemoprevention
01/2020 - 07/2002
2Drug Therapy (Chemotherapy)
01/2021 - 07/2008
1Transplantation
01/2021
1Complementary Therapies (Alternative Medicine)
10/2016